DDIS-34. HIGH-THROUGHPUT DRUG SCREENING OF FDA-APPROVED ANTINEOPLASTIC DRUGS FOR THE TREATMENT OF AGGRESSIVE MENINGIOMAS

Currently, we are facing several challenges in the treatment of meningiomas: only subtotally removable tumors, high rate of recurrence in higher-grade meningiomas, malignancy, and lack of effective chemotherapeutic agents for aggressive or inoperable tumors. For these reasons, there is an urgent nee...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Jungwirth, Gerhard, Yu, Tao, Liu, Fang, Warta, Rolf, Unterberg, Andreas, Herold-Mende, Christel
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Drug Discovery
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847632/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.285
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares